Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NYSTATIN\TRIAMCINOLONE ACETONIDE vs ODEVIXIBAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NYSTATIN\TRIAMCINOLONE ACETONIDE vs ODEVIXIBAT: Safety Overview

Metric NYSTATIN\TRIAMCINOLONE ACETONIDE ODEVIXIBAT
Total FAERS Reports 164 223
Deaths Reported 0 10
Death Rate N/A 4.5%
Hospitalizations 0 43
Average Patient Age 62.3 yrs 14.3 yrs
% Female Patients 69.0% 49.4%
FDA Approval Date N/A Jul 20, 2021
Manufacturer N/A Albireo Pharma, Inc.
Route N/A ORAL
Marketing Status N/A Prescription